FDA com­mis­sion­er Scott Got­tlieb sets some goals: Find ways to low­er drug prices, use new tech to speed de­vel­op­ment

Scott Got­tlieb start­ed his first full week as FDA com­mis­sion­er by lay­ing out some goals and guide­lines for the agency now un­der his di­rec­tion, hop­ing to al­le­vi­ate some con­cerns he’s been hear­ing about the fu­ture. In an all-hands speech to staff on Mon­day, Got­tlieb re­it­er­at­ed some now fa­mil­iar themes on what he hopes to ac­com­plish, and how every­one at the FDA is now ex­pect­ed to lend a hand.

Aside from some health ini­tia­tives on smok­ing and com­bat­ing the opi­oid ad­dic­tion cri­sis in the coun­try, Got­tlieb pledged to find new ways to low­er drug prices, push­ing through com­plex gener­ics and biosim­i­lars while lay­ing the ground­work to pre­vent any more sweet­heart deals to de­lay the ar­rival of low-cost knock­offs, im­ply­ing that he’s prepar­ing to take ac­tion on that front.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER